A recent extensive cohort of U.S. adults, demonstrated an inverse relationship between serum Klotho levels and the incidence of metabolic syndrome and proposed recombinant Klotho protein administration as a promising new treatment strategy with already favorable outcomes in mouse models [40,68,69,70]. This evidence concerns the gene KL and metabolic syndrome.